We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Investigates Omicron Variant’s Impact on Antigen Diagnostic Tests
FDA Investigates Omicron Variant’s Impact on Antigen Diagnostic Tests
FDA-authorized antigen tests for the virus that causes COVID-19 appear to work for the omicron variant but they may have less sensitivity for identifying positive samples, the agency said.